SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-19-041473
Filing Date
2019-07-23
Accepted
2019-07-23 17:11:57
Documents
3
Group Members
GILEAD THERAPEUTICS A1 UNLIMITED CO

Document Format Files

Seq Description Document Type Size
1 SC 13D a19-12867_1sc13d.htm SC 13D 133923
2 EX-99.1 a19-12867_1ex99d1.htm EX-99.1 9429
3 EX-99.2 a19-12867_1ex99d2.htm EX-99.2 741260
  Complete submission text file 0001104659-19-041473.txt   886116
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filed by) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address GEN DE WITTELAAN L11 A3 2800 MECHELEN C9 00000
Business Address GEN DE WITTELAAN L11 A3 2800 MECHELEN C9 00000 3215342900
GALAPAGOS NV (Subject) CIK: 0001421876 (see all company filings)

IRS No.: 000000000
Type: SC 13D | Act: 34 | File No.: 005-88880 | Film No.: 19968429
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences